Washington State Liquor and Cannabis Board
(WSLCB)

Members debated the future of the task force while discussing planned agency request legislation to create an Interagency Coordination Team (ICT) to regulate lab accreditation.

At the end of session, representatives considered two amendments to a bill permitting importation of CBD for use as a cannabis product additive before passing it to the Senate.

The agencies on the Cannabis Science Task Force were scheduled to describe their potential request legislation packages intended to create a new body for oversight of testing labs.

A presentation on the state medical marijuana program and confirmation of ongoing rulemaking for medical consultant certification preceded several questions by work group members.

An $81 annual fee collected from each cannabis licensee was assessed to pay for oversight of imported CBD additives before committee members recommended the bill for passage.

The full social equity task force would convene Tuesday, but cannabis policymaking appeared to be downshifting into the summer doldrums - usually the least active time of year.

Agency staff presented a new interpretive statement which offered no ‘safe harbor’ to licensees converting CBD into delta-9-THC, asserting the practice was not permitted under law.

The board received a short briefing on cannabis rulemaking, adopted a permanent ban on vitamin E acetate, and heard from a public eager to support farmers and consumers.

WSLCB Director Rick Garza shared new details about the background, leadership, and advocacy of CANNRA as he encouraged traffic safety officials to affiliate with the organization.

Legislation which would authorize the importation of CBD products into I-502 received its first finance committee public hearing.